Head-to-head comparison of three mRNA vaccines reveals differences in their stability in human blood
A study by Australian researchers compared three mRNA-LNP vaccine platforms in human blood samples, generating findings that could advance cancer treatment and vaccine design.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Fueling growth, blinding immunity: The two-way amino acid trap inside tumors
United Kingdom
-
Persistent gaps remain in hearing aid coverage, especially for older and lower-income adults, study finds
United Kingdom
-
Spatial map of the lung reveals cellular mechanisms driving damage and fibrosis in severe COVID-19
United Kingdom
-
Study finds common chemicals may alter normal breast development
United Kingdom
-
Imaging-based modalities compared for identifying at-risk MASH
United Kingdom
-
North America’s Largest Wildlife Overpass Is Working: Animal Collisions on I-25 Down 91%
United Kingdom
-
Intermittent hemodialysis not noninferior to continuous renal-replacement therapy
United Kingdom
-
New drug-delivery method offers promise in fight against neurodegenerative diseases
United Kingdom